ArticleJournal of cannabis research2026
Cannabis use and beliefs among people in recovery from substance use disorders.
Article in Journal of cannabis research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCannabis use has increased dramatically in the past decade and is currently among the most commonly used drugs in the world. Among people in recovery from substance use disorders (SUDs), cannabis is sometimes put forward as a less harmful substitute for other drugs, conflicting with abstinence-based recovery approaches. We aimed to describe cannabis use among people in recovery, explore relations among cannabis use (CU) status (Current-CU, Former-CU, Never-CU) and beliefs about social acceptability, safety, benefits, risks, and addictiveness of cannabis, and compare beliefs about the addictiveness of cannabis with that of other substances.
methodsThis study was a cross-sectional, online survey of people in recovery (n = 507) from SUDs. Cannabis use and beliefs about acceptability, benefits, risks, safety, and addictiveness were assessed, and diagnostic criteria for SUDs, including cannabis use disorder (CUD).
resultsParticipants were, on average, 47.2 (SD = 12.2) years old, 67.3% female, 81.1% White, and 93.7% non-Hispanic/Latino; 35.9% and 51.3% indicated Current- or Former-CU, respectively. Current-CU was associated with use for therapeutic purposes, and more positive beliefs about the acceptability (ps ≤ .010), safety (ps < .001), and benefits of cannabis, and risks compared to Former- or Never-CU. Those who never used cannabis rated cannabis as the least socially acceptable (ps ≤ .015), least safe (ps ≤ .036), and were least likely to endorse potential benefits. Individuals who formerly used cannabis generally showed intermediate beliefs. All participants believed cannabis was less addictive than alcohol (ps < .001), cigarettes (ps < .001), and cocaine (ps < .001), but Current-CU believed cannabis was significantly less addictive (ps < .001) than Former- and Never-CU. Participants with mild CUD believed cannabis was less addictive than those with severe CUD. Among participants with other SUDs, beliefs about the addictiveness of the respective substance did not differ by SUD severity (ps ≥ .298).
conclusionsThese findings underscore the importance of recognizing heterogeneity in cannabis use among people in recovery. Those with mild CUD believed cannabis was the least addictive while those with severe CUD believed cannabis was most addictive. In contrast, beliefs about the addictiveness of other substances were independent of SUD severity. This pattern of beliefs about addictiveness appears to be specific to cannabis. Understanding beliefs about cannabis use among people in recovery may clarify its impact on recovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.